Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT00813514
What this trial is testing

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Who this might be right for
Choroidal NeoVascularizationAge-Related Macular Degeneration
Medical University of Vienna
Testing effectiveness (Phase 2)UnknownNCT00955630
What this trial is testing

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome

Who this might be right for
Ocular Histoplasmosis Syndrome
Retina Associates of Kentucky 20
Early research (Phase 1)Looking for participantsNCT06307249
What this trial is testing

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Who this might be right for
CancerSolid TumorColorectal Cancer+7 more
Lebanese University 50
Testing effectiveness (Phase 2)Study completedNCT02504944
What this trial is testing

Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)

Who this might be right for
Retinopathy of Prematurity
Meyer Children's Hospital IRCCS 98
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Testing effectiveness (Phase 2)Study completedNCT00291629
What this trial is testing

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES

Who this might be right for
Myocardial Infarction
Seoul National University Hospital 96
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Not applicableUnknownNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Large-scale testing (Phase 3)UnknownNCT02928094
What this trial is testing

Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia

Who this might be right for
Angina, Stable
Angionetics Inc. 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Not applicableUnknownNCT02760394
What this trial is testing

Hyperbaric Oxygen Therapy in Patients With Chronic Stable Ischemic Heart Disease: An Option for Therapeutic Angiogenesis?

Who this might be right for
Ischemic Heart Disease
Assaf Harofeh MC 20
Early research (Phase 1)Study completedNCT00685854
What this trial is testing

Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

Who this might be right for
Macular Telangiectasia
National Eye Institute (NEI) 5
Not applicableEnded earlyNCT01419574
What this trial is testing

Ultrasound and Other Images of Artery Blockages

Who this might be right for
Atherosclerosis
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Not applicableStudy completedNCT00596388
What this trial is testing

Usage of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 20
Not applicableStudy completedNCT00491023
What this trial is testing

Examining Macrophage Influx and Vascularization in Chronic Pancreatitis

Who this might be right for
PancreatitisDiabetes
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT02397954
What this trial is testing

Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation 4
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Next Page